{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:15:59Z","timestamp":1773018959657,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.transproceed.2011.06.060","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T15:08:09Z","timestamp":1315753689000},"page":"2792-2797","source":"Crossref","is-referenced-by-count":20,"title":["Sirolimus-induced Pneumonitis Complicated by Pentamidine-induced Phospholipidosis in a Renal Transplant Recipient: A Case Report"],"prefix":"10.1016","volume":"43","author":[{"given":"E.J.","family":"Filippone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Beckford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.C.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.K.","family":"Awsare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2011.06.060_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2010.457","article-title":"MTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression","volume":"79","author":"Huber","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2011.06.060_bib2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01360210","article-title":"Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases","volume":"5","author":"Torres","year":"2010","journal-title":"Clin J Am Soc Nephro"},{"key":"10.1016\/j.transproceed.2011.06.060_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-2277.2010.01051.x","article-title":"MTOR inhibition: the learning curve in kidney transplantation","volume":"23","author":"Weir","year":"2010","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2011.06.060_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00007890-200109150-00008","article-title":"Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients","volume":"72","author":"Morelon","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.06.060_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1600-6135.2003.00292.x","article-title":"Sirolimus-induced pneumonitis: three cases and a review of the literature","volume":"4","author":"Haydar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.06.060_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.TP.0000118413.92211.B6","article-title":"Sirolimus-associated pulmonary toxicity","volume":"77","author":"Pham","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.06.060_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-144-7-200604040-00009","article-title":"Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients","volume":"144","author":"Champion","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2011.06.060_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ndt\/gfm420","article-title":"Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome - a single-centre experience and review of the literature","volume":"22","author":"Weiner","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2011.06.060_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.healun.2008.10.003","article-title":"Everolimus-associated pneumonitis in 3 heart transplant recipients","volume":"28","author":"Otton","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2011.06.060_bib10","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ejca.2006.03.015","article-title":"Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus","volume":"42","author":"Duran","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.transproceed.2011.06.060_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled spare-the-nephron trial","volume":"79","author":"Weir","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2011.06.060_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.transproceed.2006.01.052","article-title":"Resolution of sirolimus-induced pneumonitis after conversion to everolimus","volume":"38","author":"Rehm","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.06.060_bib13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/clinids\/24.5.854","article-title":"A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia","volume":"24","author":"O'Brien","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2011.06.060_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(93)90072-Z","article-title":"The accumulation of pentamidine and the toxic effects of the drug, its selected analogues and metabolites on isolated alveolar cells","volume":"80","author":"Jones","year":"1993","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.transproceed.2011.06.060_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/faat.1994.1119","article-title":"Inhalation toxicity of aerosolized pentamidine isethionate in rats and dogs","volume":"23","author":"Hiles","year":"1994","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.transproceed.2011.06.060_bib16","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1378\/chest.123.6.1983","article-title":"The pulmonary effects of long-term exposure to aerosol pentamidine: a 5-year surveillance study in HIV-infected patients","volume":"123","author":"Obaji","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.transproceed.2011.06.060_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0773.1994.tb01067.x","article-title":"Pentamidine accumulates in rat liver lysosomes and inhibits phospholipid degradation","volume":"74","author":"Glaumann","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.transproceed.2011.06.060_bib18","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/jm7013953","article-title":"Assessment of drug-lipid complex formation by a high-throughput Langmuir-balance and correlation to phospholipidosis","volume":"51","author":"Vitovi\u0109","year":"2008","journal-title":"J Med Chen"},{"key":"10.1016\/j.transproceed.2011.06.060_bib19","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.transproceed.2011.06.060_bib20","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/jac\/dkp372","article-title":"Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study","volume":"64","author":"Helweg-Larsen","year":"2009","journal-title":"J Antimicrob Chemother"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511009134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511009134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T23:31:34Z","timestamp":1543534294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134511009134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0041134511009134"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.06.060","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}